Introduction {#sec1-1}
============

Percutaneous radiofrequency ablation (PRFA) is a minimally invasive and widely performed local treatment for patients with liver tumors.\[[@ref1][@ref2][@ref3]\] Hepatic radiofrequency ablation is a painful procedure; patients often have pain during and/or after the procedure.\[[@ref4]\]

Thoracic paravertebral block (TPVB), which anesthetizes the spinal nerve roots and sympathetic chain in the paravertebral space, has long been used to provide unilateral chest and abdominal wall analgesia.\[[@ref5]\] The block has been used to control pain specifically of hepatic origin during percutaneous transhepatic biliary drainage\[[@ref6][@ref7]\] or after liver trauma.\[[@ref8]\]

The present study was designed to assess and compare the efficacy of the right TPVB with sedation in relieving pain during PRFA procedure of liver tumors with that of local anesthetic infiltration with sedation as a primary goal and patient and interventional radiologist satisfaction as secondary goals.

Material and Methods {#sec1-2}
====================

After obtaining approval from the Hospital Ethics Committee (30627/12/15) and informed written consent from the patients, a prospective double-blinded randomized study was carried out. Adult patients aged 50--80 years scheduled for PRFA of hepatic tumors were included in the study. Malignant liver tumors either primary or secondary were included in the study. The duration of the study was 9 months.

During the preoperative visit, every patient received an explanation of the study objectives, study protocol, and the visual analog scale (VAS) for pain (where 0= "no pain" and 10 = the "worst pain"). All patient data were used for the current study and securely maintained. Any untoward events were shared with the patients and the Hospital Ethical Committee. Patients with a Child--Pugh score more than B7, international normalized ratio value more than 1.5, platelets count \<50,000/mm^3^, history of mental disorders or allergy to local anesthetics, chest wall deformity, or regular use of analgesics were excluded from the study.

Patients were randomized using computer-generated randomization numbers into two groups using sealed opaque envelopes, and each patient chose the envelope which determined the group in which the patient was allocated. The two studied groups were group I (local anesthetic infiltration group) and group II (TPVB group).

The patients did not receive premedication. After securing peripheral intravenous (IV) line and application of routine monitoring that included electrocardiography, pulse oximetry, and noninvasive arterial blood pressure, all patients received intravenous 20 μg/kg midazolam and 0.5 μg/kg fentanyl. Supplemental oxygen at a flow rate of 4 l/min was administered via nasal cannula. Normal saline solution infusion at a rate of 4 ml/kg/h was started.

Right TPVB was performed in group II patients and sham right TPVBin group I patients in a sitting position. Following this, local anesthetic infiltration along the path of the ablation device was given for group I patients, and sham local anesthetic infiltration was given for group II in a supine position. After adequate local anesthesia over the entry site was confirmed, propofol 0.5 mg/kg IV bolus dose was given to all patients followed by an infusion of propofol 25--50 μg/kg/min to provide moderate sedation during the PRFA procedure.

Under aseptic precautions, local anesthesia was done using 2% lidocaine (5--10 ml) infiltrated percutaneously along the path of the ablation device.

Right TPVB was performed with the patient in the sitting position. The superior aspect of the spinous processes of T7 and T9 were identified and marked. Under aseptic precautions, skin anesthesia with 2 ml of 2% lidocaine was performed. A 22-gauge needle was inserted 2.5 cm lateral to the midline on the right side of the back at the selected two levels. The needle was advanced perpendicularly to the skin until the transverse process was contacted. Then, the needle was "walked off" above the transverse process and advanced until loss of resistance to the injection of air was felt. After negative aspiration of blood or cerebrospinal fluid, 25 ml of 0.5% bupivacaine was injected within the right paravertebral space at the levels of T7 and T9 (12.5 ml in each). After completion of the TPVB, the patient was returned to the supine position. Ten minutes later, loss of sensation to pinprick and cold sensations was evaluated over the targeted dermatomes (T6--11).

PRFA was done by a single radiologist blinded to the group assignment. PRFA was performed with ultrasound guidance, using expandable-tip electrode needles.

The degree of pain was assessed using VAS score; preprocedure (baseline), at 1 min, and then every 5 min during the procedure, on admission, and discharge from the post-PRFA observation area. The pain was considered mild if VAS range was 1--3, moderate if VAS range was 4--6, and severe if the VAS was ≥7. Rescue analgesia in the form of intravenous fentanyl 0.5 μg/kg was given if the VAS was ≥4 and repeated once if needed. The total dose of fentanyl administered as rescue analgesia during PRFA procedure was documented. If the patient still suffered from pain with VAS ≥4 after a repeated dose of fentanyl, total intravenous general anesthesia with propofol was administered. The number of patients requiring general anesthesia was recorded.

At the end of the PRFA procedure, propofol infusion was discontinued. The patients were transferred to the post-PRFA observation area where the vital signs were monitored for 30 min. Postprocedure analgesia in the form of paracetamol infusion (1g/8h) and tramadol (50 mg/12 h) was started if the VAS was ≥4. Before patient\'s discharge from the post-PRFA observation area, the patients and interventional radiologist were asked about the degree of their satisfaction with the anesthetic management using a four-point satisfaction scale (1 = very dissatisfied, 2 = dissatisfied, 3 = satisfied, and 4 = very satisfied).

Complications such as hypotension, bradycardia, pneumothorax, upper airway obstruction, contralateral segmental sensory blockade of TPVB, and respiratory depression (respiratory rate ≤10 breaths/min) were recorded. Hypotension was defined as a decrease of the mean arterial pressure more than 25% of the baseline value. Hypotension was treated with IV fluids (8 ml/kg) and ephedrine 10 mg, if needed. Bradycardia was defined as a decrease of the heart rate \<50 beats/min and managed with IV atropine 0.5 mg.

Statistical analysis {#sec2-1}
--------------------

Based on the results of the previous study,\[[@ref9]\] the sample size estimation showed that at least 27 patients should be included for detecting a clinically meaningful difference of VAS during PRFA of 2.1 at an α error of 0.05 and study power of 80%. Sample size was calculated and assured using power and sample size calculation software program provided by the Department of Biostatistics, Vanderbilt University. Statistical Package for the Social Sciences (SPSS) 16 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. The Kolmogorov--Smirnov test was performed to verify the assumption of normality. Continuous data were presented as mean ± standard deviation (SD) or median with interquartile range, and were compared by using Student\'s *t*-test or the Mann--Whitney *U*-test as appropriate. Categorical data were expressed as number (*n*) or percentage (%) and compared using the chi-square test. The intragroup changes of VAS score were analyzed using the Wilcoxon signed-rank test. *P* \< 0.05 was considered significant.

Results {#sec1-3}
=======

Sixty patients with liver tumors, either primary or secondary, scheduled for PRFA were enrolled in the study and randomly allocated into two groups. The demographic data including age, gender, body mass index (BMI), and the associated comorbidities were not statistically different between t groups (*P* \> 0.05). The characteristics of liver tumors and the duration of PRFA procedure were comparable between the two studied groups (*P* \> 0.05) \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic data and patient characteristics in both groups

![](JOACP-34-166-g001)

The VAS data are presented in [Table 2](#T2){ref-type="table"}. In Group I 25 patients experienced mild-to-severe pain. Twenty-one patients reported visceral and 4 patients reported referred shoulder pain. Twelve patients received a single dose of the rescue analgesia (fentanyl 0.5 μg/kg) during the PRFA procedure. Nine patients received two doses of the rescue analgesia (fentanyl 0.5 μg/kg) during the PRFA procedure. General anesthesia was conducted in 7 patients.

###### 

Visual analog scale in both groups
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In group II (TPVB) no patient reported severe pain, 5 reported moderate pain, and 13 mild pain. Fourteen patients reported visceral and 4 referred shoulder pain. Five patients received a single dose of rescue analgesia (fentanyl 0.5 μg/kg) during the PRFA procedure due to moderate pain. General anesthesia was not required.

Total consumption of the rescue analgesia during the PRFA procedure was significantly lower in group II (TPVB) than group I (*P* \< 0.05). There were no significant complications in group II (TPVB) compared to group I (*P* \> 0.05) \[[Table 3](#T3){ref-type="table"}\]. Four patients in group II (TPVB) had contralateral segmental sensory blockade from T6 to T11.

###### 

Consumption of rescue analgesia and complications
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Patient and interventional radiologist satisfaction were significantly higher in group II (TPVB) compared to group I (*P* \< 0.05) \[[Table 4](#T4){ref-type="table"}\].

###### 

Patient and radiologist satisfaction in both groups
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Discussion {#sec1-4}
==========

The results of the present study showed that the right TPVB with sedation effectively reduced the pain experienced during and after PRFA procedure, decreased the consumption of rescue analgesia during PRFA procedure, with better patient, and interventional radiologist satisfaction. The decreased requirement for opioids during the PRFA procedure is considered as an important advantage of TPVB that can improve patient safety, maintain an adequate conscious level, and preserve the respiratory drive.

From an anatomical viewpoint, the liver is innervated by the hepatic nerve plexus containing both sympathetic (T6--11) and parasympathetic (vagus) innervations.\[[@ref9]\] PRFA is associated with intense pain during and after the procedure,\[[@ref10][@ref11]\] especially during PRFA for superficial tumors or tumors located in close proximity to large hepatic vessels.\[[@ref4][@ref12]\] Pain during hepatic procedures is mediated from afferent somatic and autonomic innervations, sympathetic nerve (T6--11), and parasympathetic fiber.\[[@ref13]\]

Local anesthetic infiltration with sedation is a widely used anesthetic technique for PRFA.\[[@ref14]\] However, this technique is often associated with pain during and after PRFA procedure.\[[@ref15][@ref16][@ref17][@ref18]\] In addition, the IV sedative agents must be titrated meticulously during PRFA procedure to maintain a balance between maximum patient comfort and patient cooperation (to perform Valsalva maneuvers at the request of the radiologist).\[[@ref14]\]

TPVB is an anesthetic technique of administering local anesthetic agents close to where the spinal nerves emerge from the thoracic intervertebral foramina.\[[@ref5]\] TPVB causes sympathetic and spinal nerve fibers block in the paravertebral space without affecting the parasympathetic fibers (vagus), which is considered the main drawback of this technique.\[[@ref19]\]

TPVB has been reported as effective in controlling hepatic pain in cases of blunt abdominal trauma\[[@ref8]\] or percutaneous transhepatic biliary drainage.\[[@ref6][@ref7]\] Previous studies have reported that TPVB is an effective anesthetic technique for management of PRFA for hepatic tumors.\[[@ref9][@ref19][@ref20][@ref21]\]

Ning *et al*.\[[@ref9]\] used the right TPVB for anesthesia during PRFA of hepatic tumors in 20 patients and concluded that TPVB is a safe and effective technique for the anesthetic management of PRFA of hepatic tumors. Piccioni *et al*.\[[@ref20]\] evaluated the efficacy and safety of TPVB in 12 patients with hepatic tumors undergoing PRFA and concluded that TPVB produced satisfactory unilateral anesthesia for PRFA of liver tumors without significant side effects. Gazzera *et al*.\[[@ref21]\] evaluated the efficacy of ultrasound-guided right TPVB for anesthetic management of PRFA in 30 patients with liver tumors. Ten patients (33.3%) experienced moderate-to-severe pain that required IV sedation.

In our study, visceral pain reported in the TPVB group may be due to the inability of TPVB to block the parasympathetic nerve fibers (vagus) as well as the contralateral sympathetic fibers.\[[@ref9]\] Referred shoulder pain experienced during PRFA of liver tumors could be due to the thermal ablation of peripheral hepatic tumors that are located adjacent to the diaphragm. Phrenic nerve is not blocked by TPVB nor local anesthesia infiltration.

There were no major complications reported in either group. The safety of TPVB was reported in previous studies.\[[@ref9][@ref20][@ref21][@ref22]\] In group II, the contralateral segmental sensory blockade was reported in 4 patients (13.3%). The previously reported rate was 35%,\[[@ref9]\]20%,\[[@ref23]\] and 1.1%.\[[@ref24]\] The mechanism of the contralateral segmental sensory block may be due to epidural\[[@ref25]\] or prevertebral\[[@ref26][@ref27]\] spread of local anesthetic.

There are some limitations of our study; first is the limited number of patients included in our study. Second, the documentation of pain assessment was limited to during PRFA procedure till the discharge from the post-PRFA observation area.

In conclusion, right TPVB with sedation is an effective and safe anesthetic technique for management of patients with hepatic tumors undergoing PRFA. Right TPVB with sedation is more effective than local anesthetic infiltration with sedation in relieving pain during PRFA of hepatic tumors. Further studies are recommended to validate our findings.
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